Jeff Yass’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $60.3M | Buy |
402,200
+107,400
| +36% | +$11.7M | ﹤0.01% | 1356 |
|
|
2026
Q1 | $27.2M | Sell |
294,800
-156,100
| -35% | -$15.7M | ﹤0.01% | 1858 |
|
|
2025
Q4 | $46.1M | Buy |
450,900
+134,200
| +42% | +$12M | 0.01% | 1431 |
|
|
2025
Q3 | $19.8M | Buy |
316,700
+147,400
| +87% | +$8.02M | ﹤0.01% | 2221 |
|
|
2025
Q2 | $8.81M | Sell |
169,300
-58,100
| -26% | -$2.59M | ﹤0.01% | 3009 |
|
|
2025
Q1 | $9.69M | Buy |
227,400
+51,800
| +29% | +$2.23M | ﹤0.01% | 2575 |
|
|
2024
Q4 | $5.36M | Buy |
175,600
+51,300
| +41% | +$1.44M | ﹤0.01% | 3478 |
|
|
2024
Q3 | $2.85M | Sell |
124,300
-21,100
| -15% | -$597K | ﹤0.01% | 4639 |
|
|
2024
Q2 | $4.2M | Sell |
145,400
-250,000
| -63% | -$5.82M | ﹤0.01% | 3727 |
|
|
2024
Q1 | $8.16M | Buy |
395,400
+326,200
| +471% | +$6.99M | ﹤0.01% | 2916 |
|
|
2023
Q4 | $1.87M | Sell |
69,200
-19,300
| -22% | -$506K | ﹤0.01% | 5505 |
|
|
2023
Q3 | $2.62M | Sell |
88,500
-43,500
| -33% | -$1.53M | ﹤0.01% | 4624 |
|
|
2023
Q2 | $4.73M | Buy |
132,000
+23,400
| +22% | +$672K | ﹤0.01% | 3637 |
|
|
2023
Q1 | $2.55M | Sell |
108,600
-79,600
| -42% | -$2.27M | ﹤0.01% | 4647 |
|
|
2022
Q4 | $5.12M | Sell |
188,200
-248,100
| -57% | -$11.4M | ﹤0.01% | 3191 |
|
|
2022
Q3 | $23.5M | Buy |
436,300
+294,000
| +207% | +$15.1M | 0.01% | 1290 |
|
|
2022
Q2 | $5.74M | Buy |
142,300
+96,600
| +211% | +$4.79M | ﹤0.01% | 2966 |
|
|
2022
Q1 | $3.03M | Sell |
45,700
-18,200
| -28% | -$1.25M | ﹤0.01% | 4600 |
|
|
2021
Q4 | $6.39M | Sell |
63,900
-8,000
| -11% | -$827K | ﹤0.01% | 3346 |
|
|
2021
Q3 | $8.99M | Sell |
71,900
-24,200
| -25% | -$2.88M | ﹤0.01% | 3021 |
|
|
2021
Q2 | $11.9M | Sell |
96,100
-19,100
| -17% | -$2.57M | ﹤0.01% | 2665 |
|
|
2021
Q1 | $17.6M | Sell |
115,200
-46,900
| -29% | -$7.09M | ﹤0.01% | 2025 |
|
|
2020
Q4 | $20.9M | Sell |
162,100
-72,900
| -31% | -$8.39M | ﹤0.01% | 1699 |
|
|
2020
Q3 | $26.3M | Sell |
235,000
-36,700
| -14% | -$3.36M | 0.01% | 1261 |
|
|
2020
Q2 | $22M | Buy |
271,700
+106,000
| +64% | +$8.54M | 0.01% | 1349 |
|
|
2020
Q1 | $11.5M | Sell |
165,700
-198,200
| -54% | -$15.2M | ﹤0.01% | 1596 |
|
|
2019
Q4 | $28.4M | Buy |
363,900
+61,200
| +20% | +$4.41M | 0.01% | 1147 |
|
|
2019
Q3 | $19.3M | Buy |
302,700
+155,500
| +106% | +$13.7M | 0.01% | 1352 |
|
|
2019
Q2 | $12.7M | Sell |
147,200
-40,500
| -22% | -$3.09M | ﹤0.01% | 1662 |
|
|
2019
Q1 | $14.4M | Buy |
+187,700
| New | +$10.4M | 0.01% | 1440 |
|
Other funds holding GH
DTC
Jeff Yass's GH Position: Q2 2026 in Review
Jeff Yass increased its Guardant Health (GH) stake by 748% in Q2 2026, buying an estimated $61.8M and bringing the position to 644,138 shares worth $96.6M. The position accounts for 0.01% of the portfolio, ranked #989.
Jeff Yass first reported a position in GH in Q1 2019 and has held it in 28 quarters since. 596 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Jeff Yass held 644,138 shares of Guardant Health worth $96.6M as of Q2 2026.
- Jeff Yass bought 568,149 Guardant Health shares in Q2 2026, an estimated $61.8M.
- Guardant Health made up 0.01% of Jeff Yass's portfolio in Q2 2026, its #989 holding.
- Jeff Yass first reported a position in Guardant Health in Q1 2019 and has held it in 28 quarters since.
- 596 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.